逸達生物科技 Foresee Pharmaceuticals Co., Ltd.
About Us
Company Profile
Business Model
Board of Directors
Management Team
Scientific Advisory Board
Others
R & D
Pipeline Overview
SIF Pipeline
CAMCEVI（FP-001）：Prostate Cancer; Central Precocious Puberty
FP-014：Prostate Cancer
FP-016：Neurology; Psychiatry
Other Research Projects
NCE Pipeline
FP-025 (aderamastat): Cardiac Sarcoidosis
FP-020 (linvemastat): Asthma; COPD; IBD
FP-MMP-12 inhibitor 1: ILD, including IPF
FP-MMP-12 inhibitor 2: Neurology
FP-045 (mirivadelgat): Fanconi Anemia; PH-ILD
FP-ALDH2 Activator 1: CVRM
FP-ALDH2 Activator 2: Neurology
Media
Press Release
Media Library
Investors
Corporate Governance
Corporate Charters
Board of Directors
Others
Material Information
News & Events
Press Releases
Events & Presentations
Financial Information
Financial Results
Monthly Revenues
Sharholder Information
Annual General Meeting
Major Shareholders
FAQs
Investor Contacts
Others
Career
Benefits
Join Us
Contact Us
繁體中文
HOME
繁體中文
HOME
Investors
Financial Results
2024 Financial Results
2024 First Quarter Consolidated Financial Results
2023 Financial Results
2023 Consolidated Financial Statements
2023 Parent Company Only Financial Statements
2023 Third Quarter Consolidated Financial Results
2023 Second Quarter Consolidated Financial Results
2023 First Quarter Consolidated Financial Results
2022 Financial Results
2022 Consolidated Financial Results
2022 Parent Company Only Financial Statements
2022 Third Quarter Consolidated Financial Results
2022 Second Quarter Consolidated Financial Results
2022 First Quarter Consolidated Financial Results
2021 Financial Results
2021 Consolidated Financial Statements
2021 Parent Company Only Financial Statements
2021 Third Quarter Consolidated Financial Results
2021 S
econd
Quarter Consolidated Financial Results
2021 First Quarter Consolidated Financial Results
2020 Financial Results
2020 Consolidated Financial Results
2020 Separate Financial Results
2019 Financial Results
2019 Consolidated Financial Results
2019 Separate Financial
Results
2018 Financial Results
2018 Consolidated Financial Results
2018 Separate Financial
Results
2017 Financial Results
2017 Consolidated Financial Results
Visit Chinese Page for More Information
Financial Results
Monthly Revenues
